More than 30 percent of adults in Taiwan have hyperlipidemia (high cholesterol), the Health Promotion Administration (HPA) ...

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small ...

Intermittent explosive disorder is strongly linked to risk for other psychiatric, neurologic, and somatic conditions, ...

Cardiovascular health supplements address global CVD prevalence, featuring Omega-3s, CoQ10, and plant sterols. Production spans the US, Europe, and A ...

Dr. Tyler Perrin-Bellelo said that the initial meeting with a patient for the first time is the most important to “build a ...

COVID-19 infection, compared with influenza, is associated with increased myocarditis rates among adults in the United States.

ARWR READ THE FULL ARWR RESEARCH REPORT Business Update Plozasiran Update On January 17, 2025, Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) announced that the U.S. Food and Drug Administration (FDA) ...

The government aims to extend the average life expectancy by three years to 82 and reduce the average unhealthy period of one ...

JMP Securities reissued their market outperform rating on shares of Esperion Therapeutics (NASDAQ:ESPR – Free Report) in a research report sent to investors on Tuesday morning,Benzinga reports. They ...

SAN FRANCISCO -- Janus kinase (JAK) inhibitors appeared to be a safe, effective option for treating inflammatory bowel ...

The following is a summary of “High Density Lipoproteins Associate with Age-Related Macular Degeneration in the All of Us Research Program,” published in the January 2025 issue of Ophthalmology by ...

Lerodalcibep is an adnectin-based, small protein-binding, third generation proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor.